Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Bass, Berry & Sims Announced as Winner at 16th Annual M&A Advisor Awards

November 16, 2017
The M&A Advisor Winner 2017

Nashville, Tenn., (November 16, 2017) – The M&A Advisor announced the winners of the 16th Annual M&A Advisor Awards on Monday, November 13 at the 2017 M&A Advisor Awards. Bass, Berry & Sims was named a winner in the two categories related to the following deals: 

Bass, Berry & Sims had six separate deals recognized as a Finalist among 14 categories for this year's M&A Advisor Awards. See the details in the announcement from September 2017.

"Since 2002, we have been honoring the leading M&A transactions, companies and dealmakers. Bass, Berry & Sims was chosen from over 650 participating companies to receive the award and represents the best of the M&A industry in 2017 and earned these honors by standing out in a group of very impressive candidates," said David Fergusson, Co-CEO and President, The M&A Advisor. 

The Gala is the premier celebration of the year for the industry's leading M&A Dealmakers and was held in conjunction with the 2017 M&A Advisor Summit that featured over 500 of the industry’s leading M&A professionals participating in exclusive interactive forums led by over 35 M&A, media, academic, and industry stalwarts.

2017 M&A Advisor Winner photo

Bass, Berry & Sims attorneys Meredith Edwards Collins, Taylor Ashley, Jim Jenkins, Kris Kemp and David Cox accepting the awards at the M&A Advisor Awards.

To view a full list of the 16th Annual M&A Advisor Award winners, please visit the M&A Advisor website.

The M&A Advisor
Now in its 20th year, The M&A Advisor was founded to offer insights and intelligence on mergers and acquisitions, establishing the industry’s leading media outlet in 1998. Today, the firm is recognized as the world's premier leadership organization for mergers & acquisition, restructuring and corporate finance professionals, delivering a range of integrated services from offices in New York and London. More information can be found at www.maadvisor.com.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.